Form 4: Neuronetics Director Avinash Amin Awarded 30,000 Restricted Stock Units

Neuronetics, Inc. Director Avinash Amin has been granted 30,000 restricted stock units (RSUs), increasing his beneficial ownership to 42,500 shares.

Summary

• Avinash Amin, a Director of Neuronetics, Inc. (STIM), was granted 30,000 restricted stock units (RSUs) on May 22, 2025.
• Each RSU represents a contingent right to receive one share of Neuronetics' common stock.
• The RSU award vests on the earlier of May 22, 2026, or Mr. Amin's Board-approved separation of service from the Issuer, subject to continuous service.
• Following this transaction, Mr. Amin's total beneficial ownership of Neuronetics common stock is 42,500 shares.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is a positive signal as it aligns management's interests with shareholders, promoting long-term value creation. It is a routine compensation event and not indicative of significant operational changes.

Positives

• The grant of restricted stock units to a director aligns their interests with those of the shareholders, incentivizing long-term performance and value creation.
• Equity compensation is a common and effective way to retain key personnel and directors.

Future Outlook

The restricted stock units are set to vest on May 22, 2026, or earlier upon Board-approved separation, contingent on continuous service.

Industry Context

The granting of restricted stock units is a standard practice in the medical technology and broader corporate sectors for compensating and incentivizing directors and executives, aligning their financial interests with the company's long-term performance.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a form of equity compensation for directors is a common practice across publicly traded companies, including those in the medical device and healthcare technology sectors.
• The vesting schedule, typically over one to three years, is also standard for such awards, designed to promote long-term commitment and performance.

Related Party Transactions

• The transaction involves an equity award from Neuronetics, Inc. to one of its directors, Avinash Amin, which is considered a related party transaction.

Stakeholder Impact

• Shareholders: The RSU award aligns the director's financial interests with shareholder value, potentially leading to more focused long-term decision-making.
• Employees: No direct impact mentioned, but it reinforces the company's compensation structure for leadership.

Next Steps

• The restricted stock units will vest on May 22, 2026, or earlier upon Board-approved separation, subject to continuous service.

Key Dates

Keywords

Neuronetics, STIM, Form 4, Restricted Stock Unit, RSU, Insider Transaction, Equity Award, Director Compensation, Corporate Governance